| http://www.w3.org/ns/prov#value | - Upon product approval, Sun Pharma will be responsible for regulatory activities, including subsequent submissions, pharmacovigilance, post approval studies, manufacturing and commercialisation of the approved product [3]. 18/12/2014 18:43:12 Nov 12: PIII programme starts Dec 12 [1]. 22/11/2012 09:37:27 Trial or other data
|
